Not all PI-RADS 3 lesions are the same: Higher rate of clinically significant prostate cancer among Black men on targeted biopsy in a diverse cohort
NHB had significantly higher odds of csPCa detection on targeted biopsy of PI-RADS 3 lesions. These findings support emerging data that phenotypic appearance of prostate cancer on MRI differs by race and may be relevant for risk stratification and management counseling of PI-RADS 3 lesions.
Authors
- Alexander Sankin (ORCID: https://orcid.org/0000-0002-8296-4115)
- Rutul D. Patel (ORCID: https://orcid.org/0000-0003-4664-981X)
- K Watts
- Ahmed Aboumohamed (ORCID: https://orcid.org/0000-0002-1153-8004)
- M. Joseph
- Stephen W. Reese (ORCID: https://orcid.org/0000-0002-7486-0674)
- David Hanelin (ORCID: https://orcid.org/0009-0000-9395-6375)
- Andrewe Baca
- Ilir Agalliu
- Priya Dave
Institutions
- Albert Einstein College of Medicine (US)
- Montefiore Medical Center (US)
Publication Details
- Journal
- Urologic Oncology Seminars and Original Investigations
- Published
- 2026-02-09
- DOI
- https://doi.org/10.1016/j.urolonc.2026.110995
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00